Literature DB >> 16919849

The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia.

Lauren L Jantzie1, Gail A Rauw, Kathryn G Todd.   

Abstract

Neonatal hypoxia-ischemia (HI) is a major contributor to many neurological, psychiatric and behavioral disorders. Previous studies in our laboratory have shown that a one-time dose of doxycycline (DOXY), even when given 3h after HI insult, was neuroprotective and significantly reduced microglial activation and cleaved caspase-3 protein expression in the immature brain. In light of these data, the goal of this study was to investigate the effects of DOXY administration on amino acid neurotransmitters. Post-natal-day 7 rats received DOXY (10mg/kg) or vehicle (VEH) concomitant with the onset of HI, and were euthanized 30 min, 1, 2 or 4h post-HI (n>or=6). Extracted brains were either immediately dissected for frontal cortex, striatum and hippocampal regions, or removed in their entirety and flash frozen in isopentane for histological analyses. Dissected regions were homogenized and aliquots were prepared for high performance liquid chromatography (HPLC) analyses of amino acid levels and brain levels of DOXY. HPLC extraction revealed that systemic administration of DOXY resulted in mean drug levels of 867.1+/-376.1 ng/g of brain tissue. Histological analyses revealed microglial activation, caspase-3 activation and neuronal degeneration consistent with a mild injury in the regions most vulnerable to HI. We found that HI caused significant, time-dependent, regional changes in brain amino acids including glutamate, GABA, alanine, aspartate, asparagine, serine, glutamine, glycine and taurine. HI significantly increased glutamate levels in the hippocampus (HI+VEH=15.8+/-3.1 ng/microg versus control=11.8+/-1.4 ng/microg protein) 4h post-HI (p<0.05). Pups treated with DOXY had lower glutamate levels (13.1+/-2.4 ng/microg) when compared to VEH-treated pups (15.8+/-3.1 ng/microg), however these values failed to reach significance. In addition, DOXY-treated pups had significantly lower alanine (HI+VEH=1.1+/-0.2 ng/microg versus HI+DOXY=0.5+0.1 ng/microg) and serine (HI+VEH=1.4+/-0.4 ng/microg versus HI+DOXY=0.7+0.1 ng/microg) levels in the hippocampus, 4h post-HI. Similar normalizations and significant reductions in alanine and serine were seen in the cortex and striatum. These results show that in addition to its previously reported and well-documented anti-inflammatory and anti-apoptotic properties, DOXY has significant effects on amino acid neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919849     DOI: 10.1016/j.neuint.2006.06.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

1.  A pressurized nitrogen counterbalance to cortical glutamatergic pathway stimulation.

Authors:  Nicolas Vallee; Jean-Claude Rostain; Jean-Jacques Risso
Journal:  Neurochem Res       Date:  2010-01-29       Impact factor: 3.996

2.  Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.

Authors:  Chenju Yi; Zhiyuan Zhang; Wei Wang; Caroline Zug; Hermann J Schluesener; Zhiren Zhang
Journal:  Neurochem Res       Date:  2011-06-08       Impact factor: 3.996

3.  Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats.

Authors:  Lauren L Jantzie; Kathryn G Todd
Journal:  J Psychiatry Neurosci       Date:  2010-01       Impact factor: 6.186

4.  Comparison of nitrogen narcosis and helium pressure effects on striatal amino acids: a microdialysis study in rats.

Authors:  Nicolas Vallée; Jean-Claude Rostain; Alain Boussuges; Jean-Jacques Risso
Journal:  Neurochem Res       Date:  2008-08-27       Impact factor: 3.996

5.  Postresuscitation N-acetylcysteine treatment reduces cerebral hydrogen peroxide in the hypoxic piglet brain.

Authors:  Tze-Fun Lee; Lauren L Jantzie; Kathryn G Todd; Po-Yin Cheung
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

Review 6.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

7.  Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction.

Authors:  Letitia D Jones; Joseph W Jackson; Sanjay B Maggirwar
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

Review 8.  Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.

Authors:  Laura B Jaeger; Avindra Nath
Journal:  Dis Model Mech       Date:  2012-03-22       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.